By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Lejrvej 37-41

Værløse    DK-3500  Denmark
Phone: 45-44-47-80-80 Fax: 45-44-47-24-25



Company News
Egalet Announces FDA Advisory Committees Recommend Approval of Abuse-Deterrent ARYMO ER (Morphine Sulfate) and Reports Second Quarter 2016 Financial Results 8/5/2016 8:25:02 AM
Egalet To Host Conference Call And Webcast On August 4, 2016 To Discuss Second Quarter 2016 Financial Results 7/21/2016 7:16:14 AM
Egalet Announces Issuance Of Two New U.S. Patents For Guardian Technology 7/19/2016 6:44:33 AM
Egalet To Present At Cantor Fitzgerald Healthcare Conference 7/7/2016 7:49:31 AM
FDA Advisory Committee Meeting on August 4 for Egalet’s ARYMO; PDUFA Date is October 14 6/28/2016 11:11:59 AM
Data Presented At College On Problems Of Drug Dependence (CPDD) Meeting Show Egalet's Guardian Technology Offers Both Strong Abuse-Deterrent Features And Precision Drug Delivery 6/14/2016 1:14:03 PM
Egalet President And CEO Bob Radie Named EY Entrepreneur Of The Year 6/10/2016 10:22:56 AM
Egalet Settles Patent Litigations With Purdue Pharma L.P. 5/23/2016 6:33:56 AM
Purdue Pharma L.P. Announces Patent Agreement With Egalet And Acura Pharmaceuticals, Inc. (ACUR) 5/23/2016 6:19:58 AM
Egalet Human Abuse Potential Data At American Pain Society Annual Meeting Demonstrates Significantly Lower Intranasal Abuse Potential Of ARYMO ER Compared To MS Contin 5/12/2016 8:03:56 AM